These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15276474)

  • 61. The Role of Exercise in Cardiac Aging: From Physiology to Molecular Mechanisms.
    Roh J; Rhee J; Chaudhari V; Rosenzweig A
    Circ Res; 2016 Jan; 118(2):279-95. PubMed ID: 26838314
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Administration of granulocyte-colony stimulating factor accompanied with a balanced diet improves cardiac function alterations induced by high fat diet in mice.
    Daltro PS; Alves PS; Castro MF; Azevedo CM; Vasconcelos JF; Allahdadi KJ; de Freitas LA; de Freitas Souza BS; Dos Santos RR; Soares MB; Macambira SG
    BMC Cardiovasc Disord; 2015 Dec; 15():162. PubMed ID: 26631050
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Celecoxib prevents pressure overload-induced cardiac hypertrophy and dysfunction by inhibiting inflammation, apoptosis and oxidative stress.
    Zhang C; Wang F; Zhang Y; Kang Y; Wang H; Si M; Su L; Xin X; Xue F; Hao F; Yu L; Xu J; Liu Y; Xue M
    J Cell Mol Med; 2016 Jan; 20(1):116-27. PubMed ID: 26512452
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Balancing functions of annexin A6 maintain equilibrium between hypertrophy and apoptosis in cardiomyocytes.
    Banerjee P; Chander V; Bandyopadhyay A
    Cell Death Dis; 2015 Sep; 6(9):e1873. PubMed ID: 26335715
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Angiotensin-(1-7) administration benefits cardiac, renal and progenitor cell function in db/db mice.
    Papinska AM; Mordwinkin NM; Meeks CJ; Jadhav SS; Rodgers KE
    Br J Pharmacol; 2015 Sep; 172(18):4443-4453. PubMed ID: 26075703
    [TBL] [Abstract][Full Text] [Related]  

  • 66. iASPP, a previously unidentified regulator of desmosomes, prevents arrhythmogenic right ventricular cardiomyopathy (ARVC)-induced sudden death.
    Notari M; Hu Y; Sutendra G; Dedeić Z; Lu M; Dupays L; Yavari A; Carr CA; Zhong S; Opel A; Tinker A; Clarke K; Watkins H; Ferguson DJ; Kelsell DP; de Noronha S; Sheppard MN; Hollinshead M; Mohun TJ; Lu X
    Proc Natl Acad Sci U S A; 2015 Mar; 112(9):E973-81. PubMed ID: 25691752
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cardiomyocyte p65 nuclear factor-κB is necessary for compensatory adaptation to pressure overload.
    Javan H; Szucsik AM; Li L; Schaaf CL; Salama ME; Selzman CH
    Circ Heart Fail; 2015 Jan; 8(1):109-18. PubMed ID: 25480781
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The number of cardiac myocytes in the hypertrophic and hypotrophic left ventricle of the obese and calorie-restricted mouse heart.
    Schipke J; Banmann E; Nikam S; Voswinckel R; Kohlstedt K; Loot AE; Fleming I; Mühlfeld C
    J Anat; 2014 Nov; 225(5):539-47. PubMed ID: 25322944
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Small molecules, big effects: the role of microRNAs in regulation of cardiomyocyte death.
    Skommer J; Rana I; Marques FZ; Zhu W; Du Z; Charchar FJ
    Cell Death Dis; 2014 Jul; 5(7):e1325. PubMed ID: 25032848
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Regulation of Akt signaling by sirtuins: its implication in cardiac hypertrophy and aging.
    Pillai VB; Sundaresan NR; Gupta MP
    Circ Res; 2014 Jan; 114(2):368-78. PubMed ID: 24436432
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Are there height-dependent differences in subclinical vascular disease in hypertensive patients?
    Ferriol C; Tremols S; Jimenez C; Tura A; Sanmartín M; Pagès N; Rodríguez-Poncelas A; Paz-Bermejo M; Saez M; Coll-de-Tuero G
    J Clin Hypertens (Greenwich); 2014 Jan; 16(1):70-6. PubMed ID: 24188542
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sulforaphane protects H9c2 cardiomyocytes from angiotensin II-induced hypertrophy.
    Wu QQ; Zong J; Gao L; Dai J; Yang Z; Xu M; Fang Y; Ma ZG; Tang QZ
    Herz; 2014 May; 39(3):390-6. PubMed ID: 23784363
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inhibition of thyroid hormone receptor α1 impairs post-ischemic cardiac performance after myocardial infarction in mice.
    Mourouzis I; Kostakou E; Galanopoulos G; Mantzouratou P; Pantos C
    Mol Cell Biochem; 2013 Jul; 379(1-2):97-105. PubMed ID: 23532677
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of IGF-1 on I(K) and I(K1) Channels via PI3K/Akt Signaling in Neonatal Cardiac Myocytes.
    Millis RM; Alvin ZV; Zhao A; Haddad GE
    Int J Cell Biol; 2012; 2012():712153. PubMed ID: 22761619
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Congestive heart failure: reverse cardiac remodeling mediated by left ventricular assist devices].
    Wohlschläger J; Milting H; Stypmann J; Hager T; Schmid C; Levkau B; Baba HA
    Pathologe; 2012 May; 33(3):175-82. PubMed ID: 22576594
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Vitamin D deficiency induces cardiac hypertrophy and inflammation in epicardial adipose tissue in hypercholesterolemic swine.
    Gupta GK; Agrawal T; DelCore MG; Mohiuddin SM; Agrawal DK
    Exp Mol Pathol; 2012 Aug; 93(1):82-90. PubMed ID: 22537546
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Repression of miR-142 by p300 and MAPK is required for survival signalling via gp130 during adaptive hypertrophy.
    Sharma S; Liu J; Wei J; Yuan H; Zhang T; Bishopric NH
    EMBO Mol Med; 2012 Jul; 4(7):617-32. PubMed ID: 22367739
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pathogenesis of Chagas disease: time to move on.
    Machado FS; Tyler KM; Brant F; Esper L; Teixeira MM; Tanowitz HB
    Front Biosci (Elite Ed); 2012 Jan; 4(5):1743-58. PubMed ID: 22201990
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Influence of silencing soluble epoxide hydrolase with RNA interference on cardiomyocytes apoptosis induced by doxorubicin.
    Du G; Lv J; He L; Ma Y
    J Huazhong Univ Sci Technolog Med Sci; 2011 Jun; 31(3):324. PubMed ID: 21671172
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Levosimendan attenuates pulmonary vascular remodeling.
    Revermann M; Schloss M; Mieth A; Babelova A; Schröder K; Neofitidou S; Buerkl J; Kirschning T; Schermuly RT; Hofstetter C; Brandes RP
    Intensive Care Med; 2011 Aug; 37(8):1368-77. PubMed ID: 21626431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.